The stock is rising strictly on irrational exuberance, as Alan Greenspan used to say. Heavy speculation with little factual basis.
All of a sudden the company is about everything but Alzheimer's. A bunch of Orphan Drug status grants on other diseases. This tells us squat, as any company can apply for and get Orphan Drug Status, if they agree to work on diseases with a relatively small market, In and of it's self it is meaningless. Constant delay of data though, is a totally different story.
If you can sign up for the same service, with a huge corporation with all kids or resources and a great reputation, why would one choose the service from a tiny company with no reputation and few resources?
It's only smart to average down, if there is a very firm chance the stock will go up. If not, you are just throwing good money after bad, as the old saying goes. Predicting the future is the hard part.
Let's not give bootcop to much credit here :) Remember the increases in shares, does not go into effect immediately, it is up to the company when and how the new shares are issued. As for right now the company product looks like it has an appeal to a certain market. The chances of success seem likely, only time will tell.
While there are many red flags with the companies back ground and toxic financing. The most important factors are the complete lack of any outside interest. No interest on the part of big pharma, every time a presentation is given, there are no positive comments by anyone with any real expertise in the field, not associated with the company. Orphan Drug Status is presented as some "big deal" when in fact it means little. Analysts following the stock either have a financial interest with the company or are of such low level as to be meaningless., At this point there is little, other than the constant drone of pumpers, on this board, to support the stock, If at some point, we get support from those in the field who know Alzheimer's disease, things may change. For now, the stock is wallowing very near collapse. The small float, coupled with a large number of individual investors who seriously over bought on "emotions and greed", will likely lead to a sharp sudden drop in share price down the road, Don't be caught holding to many worthless shares.